Automated cell culture systems
Robotic and software platforms that automate the closed, GMP-grade cell culture and manufacturing steps behind cell and gene therapies — end-to-end automated manufacturing platforms, robotic drug-product handling, and the scheduling/orchestration software coordinating multi-instrument automated workflows — sold by four specialists (Cellares, Multiply Labs, Ori Biotech, HighRes Biosolutions) targeting the labor-intensive, variability-prone manual cell-therapy manufacturing process.
1 · What it gives
Automated cell culture systems replace the manual, technician-dependent steps of cell and gene therapy manufacturing — cell isolation, activation, transduction, expansion and formulation — with closed, robotically-operated platforms designed to cut cost, reduce operator-introduced variability and scale production beyond what a manual cleanroom process can support. The category spans full end-to-end manufacturing platforms that automate an entire cell-therapy production run inside a single closed system, robotics-driven modular manufacturing that automates specific high-touch steps (such as drug-product fill and finish) using standard collaborative robots, and the scheduling and orchestration software that coordinates multiple automated instruments into a single validated workflow. Demand is driven directly by the economics of cell-therapy manufacturing: a fully manual process is both expensive (cited cost reductions from automation reach 74% in one documented case) and difficult to scale to the patient volumes autologous and allogeneic cell therapies increasingly require, making automated systems a commercial necessity rather than an optional efficiency upgrade for cell-therapy developers and CDMOs.
The key directions of automated cell culture systems are:
- End-to-end automated manufacturing platforms: closed systems that automate an entire cell-therapy production run — isolation through formulation — inside a single platform, positioned as an alternative to a traditional CDMO’s manual cleanroom process.
- Robotics-driven modular manufacturing: collaborative-robot-based automation of specific high-touch manufacturing steps (drug-product handling, fill-finish) integrated into a broader manual or semi-automated process rather than replacing the entire workflow.
- Workflow scheduling and orchestration software: software that coordinates multiple automated lab instruments (liquid handlers, incubators, analyzers) into a single scheduled, auditable workflow, the control layer above the physical automation hardware.
- AI-assisted process control: software layers increasingly integrating AI agents and toolkits into the scheduling and execution layer, positioned as the “open execution layer” connecting automated lab hardware to AI-driven process decisions.
Sectoral value chain#
[Cell Source Material] ──> [Automated Isolation/Activation] ──> [Automated Expansion/Culture] ──> [Automated Formulation]
│
(Workflow Scheduling/Orchestration)
│
▼
[Patient-Ready Cell Product] <─── [QC and Release Testing] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Cell source material | Patient (autologous) or donor (allogeneic) starting cell material entering the manufacturing process. | In: Apheresis material or donor cell source. Out: Source cells ready for isolation/activation. |
| Automated isolation/activation | Robotically isolating and activating the target cell population within a closed system. | In: Source cells. Out: Isolated, activated cell population. |
| Automated expansion/culture | Automated bioreactor or culture-vessel expansion of the activated cell population to manufacturing scale. | In: Activated cells. Out: Expanded cell population at target cell count. |
| Automated formulation | Robotically formulating the expanded cell population into the final drug-product format for fill-finish. | In: Expanded cell population. Out: Formulated drug product ready for fill-finish. |
| QC and release testing | Testing the formulated product against release specifications, increasingly scheduled and tracked through the same orchestration software as the manufacturing steps. | In: Formulated drug product. Out: QC-released or rejected batch. |
| Patient-ready cell product | The released, patient-ready autologous or allogeneic cell therapy product. | In: QC-released batch. Out: Patient-ready cell therapy product. |
Cross-cutting technologies of the sector:
- Closed cell-therapy automation: end-to-end automated platforms that keep the entire manufacturing process within a closed, robotically-operated system from isolation through formulation.
- Robotic biomanufacturing cell line: collaborative-robot automation of specific high-touch manufacturing steps within a broader cell-therapy production line.
- Lab workflow orchestration software: scheduling and coordination software that sequences multiple automated instruments into a single validated, auditable workflow.
2 · What it replaces 3 · matched by industry
| D3E– | Agricultural spraying drones instead of knapsack and manned aerial spraying Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying | EAC |
| D2E– | Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale … | MACRO |
| D3E2 | Genomic selection in dairy cattle breeding instead of progeny testing Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs) | BREED |
3 · How to implement 6 steps
- 1Cell source materialPatient (autologous) or donor (allogeneic) starting cell material enters the manufacturing process, the common starting point regardless of which automated platform processes it.
- 2Automated isolation/activationEquipment & engineeringThe target cell population is robotically isolated and activated within a closed system, eliminating the manual open-processing steps that introduce operator-dependent variability in conventional manufacturing.Who can do this step matched automaticallyN.Thing South Koreaindustrial scale“Services: turnkey delivery including design, construction, and operations consulting; in-house cultivation and supply to grocery, food service, catering, and manufacturing.”Cell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”Consorcio Azucarero de Empresas Industriales Dominican Republic✓ ISO 9001 126,058 tons industrial scale“In addition to the latest machinery and equipment, our company has additional resources that complement industrial procedures, including computerized management systems, biometric …”Daedong South Korea“Daedong is a South Korean agricultural machinery manufacturer founded in 1947 and headquartered in Daegu.”163,050 tonnes“[China Everbright Environment Group Limited — China Everbright Environment Group is a leading integrated environmental protection conglomerate with diversified core businesses in …”
- 3Automated expansion/cultureFermentation & cultivationEquipment & engineeringThe activated cell population is expanded to manufacturing scale within an automated bioreactor or culture-vessel system, scheduled and tracked by the platform’s orchestration layer.Who can do this step matched automaticallyCell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”N.Thing South Koreaindustrial scale“Services: turnkey delivery including design, construction, and operations consulting; in-house cultivation and supply to grocery, food service, catering, and manufacturing.”Absolute Indiaindustrial scale“Uses precision fermentation and proprietary gene-editing tools to deliver diabetes-friendly nutrition for 600 million+ people.”Consorcio Azucarero de Empresas Industriales Dominican Republic✓ ISO 9001 126,058 tons industrial scale“In addition to the latest machinery and equipment, our company has additional resources that complement industrial procedures, including computerized management systems, biometric …”Daedong South Korea“Daedong is a South Korean agricultural machinery manufacturer founded in 1947 and headquartered in Daegu.”
- 4Automated formulationFormulation & blendingEquipment & engineeringThe expanded cell population is robotically formulated into its final drug-product format, the step immediately preceding fill-finish.Who can do this step matched automaticallyN.Thing South Koreaindustrial scale“Services: turnkey delivery including design, construction, and operations consulting; in-house cultivation and supply to grocery, food service, catering, and manufacturing.”Cell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”Consorcio Azucarero de Empresas Industriales Dominican Republic✓ ISO 9001 126,058 tons industrial scale“In addition to the latest machinery and equipment, our company has additional resources that complement industrial procedures, including computerized management systems, biometric …”Daedong South Korea“Daedong is a South Korean agricultural machinery manufacturer founded in 1947 and headquartered in Daegu.”163,050 tonnes“[China Everbright Environment Group Limited — China Everbright Environment Group is a leading integrated environmental protection conglomerate with diversified core businesses in …”Rossari Biotech (NSE) India✓ ISO 9001 industrial scale“The company also announced a new greenfield blending facility in Thailand to boost Southeast Asia operations and smarter capacity utilization across its HPPC, TSC, and AHN …”
- 5QC and release testingTesting & analyticsThe formulated product is tested against release specifications, increasingly scheduled and logged through the same orchestration software coordinating the upstream manufacturing steps.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”BRAIN Biotech Germany✓ ISO 9001 industrial scale“As a contract research organization (CRO), we provide smart, rapid, and effective solutions using cutting-edge technologies to drive customer success.”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
- 6Patient-ready cell productThe QC-released product moves forward as a patient-ready autologous or allogeneic cell therapy, the end point the entire automated manufacturing run was built to reach reliably and at scale.
4 · Who delivers
Matched suppliers (matched automatically)
| Caladan Bio | United States | Producer | active |
| Lonza Group | Switzerland | Producer | active |
| BIONET | Spain | Equipment | active |
| Novartis | Switzerland | Producer | active |
| PBS Biotech | United States | Equipment | active |
| AGC Biologics | United States | Producer | active |
| Ginkgo Bioworks | United States | Producer | active |
| Cryoport Systems | United States | Producer | active |
| Integriculture | Japan | Equipment | active |
| Paris Biofoundry (France) | France | Research / RTO | active |
| Pensées | South Korea | Producer | active |
| ROWAIN | South Korea | Services / consulting | active |
In the services and supply catalogue 3 · paid service
Engineering, EPC & validation · Laboratory & analytical instruments · Spare parts, service & calibration
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Cellares | 🇺🇸 USA | Cell Shuttle, smart factories (IDMO) | End-to-end closed automated cell-therapy manufacturing | commercial |
| Ori Biotech | 🇬🇧 UK | IRO platform | FDA Advanced Manufacturing Technology designation | commercial |
| Multiply Labs | 🇺🇸 USA | Cobot-driven cell-therapy manufacturing automation | 74% documented cost reduction using Universal Robots cobots | commercial |
| HighRes Biosolutions | 🇺🇸 USA | Cellario OS workflow orchestration software | Multi-instrument scheduling, AI-agent integration (NVIDIA BioNeMo) | commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The United States hosts two specialists at opposite ends of the automation spectrum: a full end-to-end closed-platform manufacturer and a modular robotics integrator, plus the orchestration-software layer coordinating automated instrument workflows more broadly.
End-to-end automated manufacturing, modular robotics, workflow orchestration software#
- Cellares: operates the Cell Shuttle automated cell-therapy manufacturing platform within its “smart factory” (IDMO) model, with a documented case of first-patient dosing on product manufactured entirely on the platform for a partner’s cell therapy, positioned as an alternative to conventional CDMO manual manufacturing.
- Multiply Labs: deploys collaborative-robot-driven automation for cell-therapy bio-manufacturing, with a documented 74% cost-reduction case study using Universal Robots cobots, targeting the specific high-touch manual steps within a broader manufacturing line rather than the entire process.
- HighRes Biosolutions: produces the Cellario workflow-scheduling and orchestration software coordinating multiple automated lab instruments into a single scheduled workflow, recently extending the platform toward AI-agent integration (including an NVIDIA BioNeMo toolkit connection) as an “open execution layer” for automated lab operations.
European Union
Europe is represented by the UK specialist whose IRO platform recently earned a distinct FDA manufacturing-technology designation, evidence its automated approach is gaining regulatory as well as commercial traction.
Automated cell and gene therapy manufacturing, regulatory-designated platforms#
- Ori Biotech (UK): operates the IRO automated cell and gene therapy manufacturing platform, which received FDA Advanced Manufacturing Technology (AMT) designation and has a documented strategic-partnership dosing milestone with a cell-therapy developer, positioning it alongside Cellares as a full-platform automated-manufacturing alternative to conventional CDMO processes.
China
China’s presence in automated cell culture systems is limited to general lab-automation and cell-therapy manufacturing market coverage rather than a confirmed dedicated automation-platform producer: no domestic company’s own-domain page confirming a specific automated cell-culture manufacturing platform was found in this screen.
Market coverage only, no confirmed dedicated automation-platform producer#
- General market visibility only: searches return industry reporting on China’s cell-therapy manufacturing capacity growth rather than a specific domestic company’s own commercial automated cell-culture platform.
- No producer tabled: without an own-domain page confirming a specific Chinese company’s automated cell-culture manufacturing platform, none is listed here — an evidence gap to revisit as the category develops, not a claim that Chinese cell-therapy manufacturers are absent generally.
6 · Money: tenders & grants
| Grant | Automated Scientific Discovery – Food (RAISE pilot) European Commission · EU | Feb 2, 2027 71 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 136 days |
| Grant | Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU | Feb 2, 2027 71 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 141 days |
| Grant | Deploying circular systemic solutions through living labs in cities and regions (Circular Cities and Regions … European Commission · EU | Apr 8, 2027 136 days |
7 · Tech stack & innovations
The stack spans full-platform hardware automation, modular robotics automation of specific steps, and the software orchestration layer that increasingly ties automated instruments into an AI-assisted control system.
- End-to-End Closed Manufacturing Platforms:
- Cellares’s Cell Shuttle and Ori Biotech’s IRO platform both automate an entire cell-therapy manufacturing run inside a single closed system, the most capital-intensive but most comprehensive automation tier in the category.
- Both platforms have moved past pilot status to documented commercial traction — first-patient dosing on Cellares’s platform, and FDA AMT designation plus a partner dosing milestone for Ori Biotech — evidence the end-to-end approach has cleared real regulatory and manufacturing validation bars, not just demonstrated feasibility.
- Modular Robotics Automation:
- Multiply Labs applies collaborative robots to specific high-touch manufacturing steps rather than automating the entire process, a lower-capital-intensity entry point that still delivers a documented, substantial cost reduction.
- This tier targets facilities retrofitting automation into an existing manual process rather than facilities building a fully automated line from scratch.
- Workflow Orchestration and AI Integration:
- HighRes Biosolutions’s Cellario software sits above the physical automation hardware, scheduling and coordinating multiple instruments (liquid handlers, incubators, analyzers) into a single auditable workflow rather than automating a manufacturing step itself.
- The platform’s recent extension toward AI-agent integration, including a named NVIDIA toolkit connection, signals the orchestration layer is becoming the point where AI-driven process decisions get connected to physical lab automation, a distinct and newer commercial direction from the scheduling function alone.
Sources 4 · 0 independent · 4 producer sites
Producers' own sites 4
- Cellares producer checked 2026-07-13 · link not kept
- Multiply labs producer checked 2026-01-27 · link not kept
- Ori biotech producer checked 2026-05-27 · link not kept
- Highres biosolutions producer checked 2026-06-30 · link not kept